Celldex Therapeutics buy Wells Fargo & Company
Start price
27.09.24
/
50%
€28.40
Target price
27.09.25
-
Performance (%)
-20.42%
End price
28.09.25
€22.60
Summary
This prediction ended on 28.09.25 with a price of €22.60. The price of Celldex Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.42%. Wells_Fargo___Compan has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 3.057% | 3.057% | 67.545% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) was upgraded by analysts at Wells Fargo & Company from a "hold" rating to a "strong-buy" rating.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
56.63%
08.05.26
08.05.26
